BioWorld Science

Dec. 12, 2002

View Archived Issues

Ilex sublicenses CD52 diagnostic rights to Ventana

Read More

Novel alphav integrin antagonists and their use in osteoporosis

Read More

Vanilloid VR1 antagonists identified at GSK

Read More

Merck & Co. synthesizes new alpha2/alpha3-selective GABA-A agonist

Read More

Gruenenthal presents novel opioid agents for diarrhea, IBS, pain and immunomodulation

Read More

Tetracyclic MCH receptor modulators identified by Tularik scientists

Read More

Phase I testing of ACP-HIP cleared to begin by Health Canada

Read More

Two series of azole-based antifungal agents prepared and tested at Aventis

Read More

New caspase activators in Cytovia development pipeline

Read More

RenaZorb begins testing in animals

Read More

Thuris to evaluate CNCDS's compounds in antiaging and Alzheimer's models

Read More

European approval for room-temperature storage of Betaferon

Read More

Vectura and GSK sign dry powder drug formulation agreement

Read More

AMD-3100 shows potential in myocardial infarction and for CD34+ cell mobilization/collection

Read More

Apomine as a new therapeutic approach to multiple myeloma

Read More

NanoCarrier and Kirin collaborate on anticancer therapeutics

Read More

Phase I testing of Abiogen's OGP drug to begin in Italy

Read More

CTCE-0021 rapidly mobilizes PMNs and hematopoietic progenitor cells

Read More

Nastech's intranasal morphine product shows rapid absorption and good pain relief

Read More

Pharmacokinetic studies in monkeys suggest feasibility of s.c. administration of PRO-38747

Read More

Exherin cleared to enter phase I trials in Canada

Read More

NeoTherapeutics renamed Spectrum Pharmaceuticals

Read More

CTA filed in Europe for MDX-018 in autoimmune indication

Read More

Inhibition of Src tyrosine kinases as a novel approach to the treatment of CML

Read More

Treatment begins in phase II trial of myoblast cell transplantation

Read More